The American Diabetes Association’s (ADA) annual Standards of Medical Care in Diabetes includes new and updated guidance for managing patients with diabetes and prediabetes based on the latest scientific evidence and clinical trials. For the fourth consecutive year, the ACC endorsed the section focused on “Cardiovascular Disease and Risk Management.”

The Standards of Care document, published in the January 2022 issue of Diabetes Care, provides the latest in comprehensive, evidence-based recommendations for the diagnosis and treatment of youth and adults with type 1, type 2, or gestational diabetes. It also includes strategies for the prevention or delay of type 2 diabetes and associated comorbidities and recommends therapeutic approaches that can reduce complications, mitigate cardiovascular and renal risk, and improve health outcomes. 

Among the most notable updates and additions:

• Guidance on first-line therapy determined by comorbidities. 
• Recommended screening for prediabetes and diabetes beginning at age 35 for all people.
• Changes to gestational diabetes mellitus recommendations regarding when to test and in whom testing should be done.
• Updated recommendations on technology selection based on individual and caregiver considerations, ongoing education on use of devices, continued access to devices across payers, support of students using devices in school settings, use of telehealth visits, and early initiation of technology. 

Other notable changes include more information on managing nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in conjunction with diabetes, the role of health numeracy in diabetes prevention and management, cognitive impairment and diabetes, and COVID-19 updates based on evolving evidence.

Clinical Topics: Congenital Heart Disease and Pediatric Cardiology, COVID-19 Hub, Diabetes and Cardiometabolic Disease, CHD and Pediatrics and Prevention, CHD and Pediatrics and Quality Improvement

Keywords: Telemedicine, Outcome Assessment, Health Care, Risk Management, Caregivers, COVID-19, Standard of Care, Cardiovascular Diseases, Prediabetic State, Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Diabetes, Gestational, Adolescent

< Back to Listings